Home/ Supplements/ Nmn/ Liposomal NMN

Liposomal NMN

product on market Capsule GenuinePurity Safety: 60/100
60/100

Review before taking

  • Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Beta-Nicotinamide Mononucleotide is researched for its role in boosting NAD+ levels to support cellular energy. Evidence for these effects in humans remains limited. Due to a lower safety score, potential concerns regarding long-term tolerability should be noted.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

✨ AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 250mg of Beta-Nicotinamide Mononucleotide, which is over seven times the recommended upper intake limit.

Label

Product Label

Label for Liposomal NMN
Open Full PDF View on NIH DSLD →
Details

Label Data

1 VCapsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 7.1× (UL: 35 mg) 196 studies (A:5, B:63)

Other Ingredients

Cellulose Phospholipid Complex Microcrystalline Cellulose Silicon Dioxide Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: 1 capsule daily preferably with meals or as directed by a healthcare professional.

Warnings & Precautions

Caution: Do not exceed recommended dose.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition including any cardiovascular disorder, hypotension (low blood pressure) and Parkinson's disease.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or persons with a known medical condition including any cardiovascular disorder, hypotension (low blood pressure) and Parkinson's disease. Keep out of reach of children.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, fish, and crustacean shellfish.

Do not purchase if seal is broken.

Formulation Notes

Promotes cellular regeneration, mitochondrial function & DNA health

Additional Information

Protect from heat, light and moisture. Store at 15 degrees C - 30 degrees C (59-86 degrees F).

Please recycle

Made in USA GMP Sourced from a GMP Certified Facility

Metadata

Product Details

UPC / SKU6 28043 00191 6
DSLD Entry Date2025-07-24
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandGenuinePurity
DSLD ID336117
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

NMN Nicotinamide Mononucleotide 250 mg
Double Wood Supplements · Capsule
100
Nicotinamide Mononucleotide 125 mg
SuperSmart · Capsule
100
NMN Nicotinamide Mononucleotide 250 mg
ForestLeaf · Capsule
100
LIPO NMN
Alive By Science · Capsule
100
NMN Nicotinamide Mononucleotide
GeneX Formulas · Capsule
100
View all Nmn products →
Nmn research Best Nmn All Nmn products More from GenuinePurity View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.